- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
Carrot tan trend on social media; New drug delivery patch inspired by octopus tentacle; Pfizer plant resumes production - Morning Medical Update
The top news stories in primary care today.
doctor morning desk © Alena Kryazheva - stock.adobe.com
Carrot tan trend on social media
Overloading on carrots to get a tan is the latest social media trend. Excessive carrot consumption leads to buildup of a substance called beta-carotene, leading to carotenemia. Carotenemia causes an orange glow, particularly on the feed and hands. Experts do not condone this trend.
New drug delivery patch inspired by octopus tentacle
A research team is developing a new delivery patch inspired by the suction cups of an octopus tentacle. The patch would stick to the inside of the cheek and administer peptides without injection. Human and animal trials have gone well so far and researchers remain optimistic.
Pfizer plant resumes production
The tornado-damaged Pfizer plant in North Carolina has resumed production on some lines, the company announced this week. Thirteen of the highest priority medicines are expected to ship to distribution centers in the fourth quarter of this year. Full production across all three sites is expected by the end of this yea
